| 內容 |
| ALIMENTARY TRACT AND METABOLISM |
| A01 STOMATOLOGICAL PREPARATIONS |
| A01A STOMATOLOGICAL PREPARATIONS |
| A01AA Caries prophylactic agents |
| A01AB Antiinfectives and antiseptics for local oral treatment |
| A01AC Corticosteroids for local oral treatment |
| A01AD Other agents for local oral treatment |
| A02 DRUGS FOR ACID RELATED DISORDERS |
| A02A ANTACIDS |
| A02AA Magnesium compounds |
| A02AB Aluminium compounds |
| A02AC Calcium compounds |
| A02AD Combinations and complexes of aluminium, calcium and magnesium compounds |
| A02AF Antacids with antiflatulents |
| A02AG Antacids with antispasmodics |
| A02AH Antacids with sodium bicarbonate |
| A02AX Antacids, other combinations |
| A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) |
| A02BA H2-receptor antagonists |
| A02BB Prostaglandins |
| A02BC Proton pump inhibitors |
| A02BD Combinations for eradication of Helicobacter pylori |
| A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) |
| A02X OTHER DRUGS FOR ACID RELATED DISORDERS |
| A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS |
| A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS |
| A03AA Synthetic anticholinergics, esters with tertiary amino group |
| A03AB Synthetic anticholinergics, quaternary ammonium compounds |
| A03AC Synthetic antispasmodics, amides with tertiary amines |
| A03AD Papaverine and derivatives |
| A03AE Serotonin receptor antagonists |
| A03AX Other drugs for functional gastrointestinal disorders |
| A03B BELLADONNA AND DERIVATIVES, PLAIN |
| A03BA Belladonna alkaloids, tertiary amines |
| A03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds |
| A03C ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS |
| A03CA Synthetic anticholinergic agents in combination with psycholeptics |
| A03CB Belladonna and derivatives in combination with psycholeptics |
| A03CC Other antispasmodics in combination with psycholeptics |
| A03D ANTISPASMODICS IN COMBINATION WITH ANALGESICS |
| A03DA Synthetic anticholinergic agents in combination with analgesics |
| A03DB Belladonna and derivatives in combination with analgesics |
| A03DC Other antispasmodics in combination with analgesics |
| A03E ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS |
| A03EA Antispasmodics, psycholeptics and analgesics in combination |
| A03ED Antispasmodics in combination with other drugs |
| A03F PROPULSIVES |
| A03FA Propulsives |
| A04 ANTIEMETICS AND ANTINAUSEANTS |
| A04A ANTIEMETICS AND ANTINAUSEANTS |
| A04AA Serotonin (5HT3) antagonists |
| A04AD Other antiemetics |
| A05 BILE AND LIVER THERAPY |
| A05A BILE THERAPY |
| A05AA Bile acid and derivatives |
| A05AB Preparations for biliary tract therapy |
| A05AX Other drugs for bile therapy |
| A05B LIVER THERAPY, LIPOTROPICS |
| A05BA Liver therapy |
| A05C DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION |
| A06 DRUGS FOR CONSTIPATION |
| A06A DRUGS FOR CONSTIPATION |
| A06AA Softeners, emollients |
| A06AB Contact laxatives |
| A06AC Bulk-forming laxatives |
| A06AD Osmotically acting laxatives |
| A06AG Enemas |
| A06AH Peripheral opioid receptor antagonist |
| A06AX Other drugs for constipation |
| A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS |
| A07A INTESTINAL ANTIINFECTIVES |
| A07AA Antibiotics |
| A07AB Sulfonamides |
| A07AC Imidazole derivatives |
| A07AX Other intestinal antiinfectives |
| A07B INTESTINAL ADSORBENTS |
| A07BA Charcoal preparations |
| A07BB Bismuth preparations |
| A07BC Other intestinal adsorbents |
| A07C ELECTROLYTES WITH CARBOHYDRATES |
| A07CA Oral rehydration salt formulations |
| A07D ANTIPROPULSIVES |
| A07DA Antipropulsives |
| A07E INTESTINAL ANTIINFLAMMATORY AGENTS |
| A07EA Corticosteroids acting locally |
| A07EB Antiallergic agents, excl. corticosteroids |
| A07EC Aminosalicylic acid and similar agents |
| A07F ANTIDIARRHEAL MICROORGANISMS |
| A07FA Antidiarrheal microorganisms |
| A07X OTHER ANTIDIARRHEALS |
| A07XA Other antidiarrheals |
| A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS |
| A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS |
| A08AA Centrally acting antiobesity products |
| A08AB Peripherally acting antiobesity products |
| A08AX Other antiobesity drugs |
| A09 DIGESTIVES, INCL. ENZYMES |
| A09A DIGESTIVES, INCL. ENZYMES |
| A09AA Enzyme preparations |
| A09AB Acid preparations |
| A09AC Enzyme and acid preparations, combinations |
| A10 DRUGS USED IN DIABETES |
| A10A INSULINS AND ANALOGUES |
| A10AB Insulins and analogues for injection, fast-acting |
| A10AC Insulins and analogues for injection, intermediate-acting |
| A10AD Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting |
| A10AE Insulins and analogues for injection, long-acting |
| A10AF Insulins and analogues for inhalation |
| A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| A10BA Biguanides |
| A10BB Sulfonylureas |
| A10BC Sulfonamides (heterocyclic) |
| A10BD Combinations of oral blood glucose lowering drugs |
| A10BF Alpha glucosidase inhibitors |
| A10BG Thiazolidinediones |
| A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors |
| A10BJ Glucagon-like peptide-1 receptor (GLP-1) analogues |
| A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors |
| A10BX Other blood glucose lowering drugs, excl. insulins |
| A10X OTHER DRUGS USED IN DIABETES |
| A10XA Aldose reductase inhibitors |
| A11 VITAMINS |
| A11A MULTIVITAMINS, COMBINATIONS |
| A11AA Multivitamins with minerals |
| A11AB Multivitamins, other combinations |
| A11B MULTIVITAMINS, PLAIN |
| A11BA Multivitamins, plain |
| A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO |
| A11CA Vitamin A, plain |
| A11CB Vitamin A and D in combination |
| A11CC Vitamin D and analogues |
| A11D VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 |
| A11DA Vitamin B1, plain |
| A11DB Vitamin B1 in combination with vitamin B6 and/or vitamin B12 |
| A11E VITAMIN B-COMPLEX, INCL. COMBINATIONS |
| A11EA Vitamin B-complex, plain |
| A11EB Vitamin B-complex with vitamin C |
| A11EC Vitamin B-complex with minerals |
| A11ED Vitamin B-complex with anabolic steroids |
| A11EX Vitamin B-complex, other combinations |
| A11G ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS |
| A11GA Ascorbic acid (vitamin C), plain |
| A11GB Ascorbic acid (vitamin C), combinations |
| A11H OTHER PLAIN VITAMIN PREPARATIONS |
| A11HA Other plain vitamin preparations |
| A11J OTHER VITAMIN PRODUCTS, COMBINATIONS |
| A11JA Combinations of vitamins |
| A11JB Vitamins with minerals |
| A11JC Vitamins, other combinations |
| A12 MINERAL SUPPLEMENTS |
| A12A CALCIUM |
| A12AA Calcium |
| A12AX Calcium, combinations with vitamin D and/or other drugs |
| A12B POTASSIUM |
| A12BA Potassium |
| A12C OTHER MINERAL SUPPLEMENTS |
| A12CA Sodium |
| A12CB Zinc |
| A12CC Magnesium |
| A12CD Fluoride |
| A12CE Selenium |
| A12CX Other mineral products |
| A13 TONICS |
| A13A TONICS |
| A14 ANABOLIC AGENTS FOR SYSTEMIC USE |
| A14A ANABOLIC STEROIDS |
| A14AA Androstan derivatives |
| A14AB Estren derivatives |
| A14B OTHER ANABOLIC AGENTS |
| A15 APPETITE STIMULANTS |
| A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| A16AA Amino acids and derivatives |
| A16AB Enzymes |
| A16AX Various alimentary tract and metabolism products |
| BLOOD AND BLOOD FORMING ORGANS |
| B01 ANTITHROMBOTIC AGENTS |
| B01A ANTITHROMBOTIC AGENTS |
| B01AA Vitamin K antagonists |
| B01AB Heparin group |
| B01AC Platelet aggregation inhibitors excl. heparin |
| B01AD Enzymes |
| B01AE Direct thrombin inhibitors |
| B01AF Direct factor Xa inhibitors |
| B01AX Other antithrombotic agents |
| B02 ANTIHEMORRHAGICS |
| B02A ANTIFIBRINOLYTICS |
| B02AA Amino acids |
| B02AB Proteinase inhibitors |
| B02B VITAMIN K AND OTHER HEMOSTATICS |
| B02BA Vitamin K |
| B02BB Fibrinogen |
| B02BC Local hemostatics |
| B02BD Blood coagulation factors |
| B02BX Other systemic hemostatics |
| B03 ANTIANEMIC PREPARATIONS |
| B03A IRON PREPARATIONS |
| B03AA Iron bivalent, oral preparations |
| B03AB Iron trivalent, oral preparations |
| B03AC Iron, parenteral preparations |
| B03AD Iron in combination with folic acid |
| B03AE Iron in other combinations |
| B03B VITAMIN B12 AND FOLIC ACID |
| B03BA Vitamin B12 (cyanocobalamin and analogues) |
| B03BB Folic acid and derivatives |
| B03X OTHER ANTIANEMIC PREPARATIONS |
| B03XA Other antianemic preparations |
| B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS |
| B05A BLOOD AND RELATED PRODUCTS |
| B05AA Blood substitutes and plasma protein fractions |
| B05AX Other blood products |
| B05B I.V. SOLUTIONS |
| B05BA Solutions for parenteral nutrition |
| B05BB Solutions affecting the electrolyte balance |
| B05BC Solutions producing osmotic diuresis |
| B05C IRRIGATING SOLUTIONS |
| B05CA Antiinfectives |
| B05CB Salt solutions |
| B05CX Other irrigating solutions |
| B05D PERITONEAL DIALYTICS |
| B05DA Isotonic solutions |
| B05DB Hypertonic solutions |
| B05X I.V. SOLUTION ADDITIVES |
| B05XA Electrolyte solutions |
| B05XB Amino acids |
| B05XC Vitamins |
| B05XX Other i.v. solution additives |
| B05Z HEMODIALYTICS AND HEMOFILTRATES |
| B05ZA Hemodialytics, concentrates |
| B05ZB Hemofiltrates |
| B06 OTHER HEMATOLOGICAL AGENTS |
| B06A OTHER HEMATOLOGICAL AGENTS |
| B06AA Enzymes |
| B06AB Hem products |
| B06AC Drugs used in hereditary angioedema |
| B06AX Other hematological agents |
| CARDIOVASCULAR SYSTEM |
| C01 CARDIAC THERAPY |
| C01A CARDIAC GLYCOSIDES |
| C01AA Digitalis glycosides |
| C01AB Scilla glycosides |
| C01AC Strophantus glycosides |
| C01AX Other cardiac glycosides |
| C01B ANTIARRHYTHMICS, CLASS I AND III |
| C01BA Antiarrhythmics, class Ia |
| C01BB Antiarrhythmics, class Ib |
| C01BC Antiarrhythmics, class Ic |
| C01BD Antiarrhythmics, class III |
| C01BG Other antiarrhythmics, class I and III |
| C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| C01CA Adrenergic and dopaminergic agents |
| C01CE Phosphodiesterase inhibitors |
| C01CX Other cardiac stimulants |
| C01D VASODILATORS USED IN CARDIAC DISEASES |
| C01DA Organic nitrates |
| C01DB Quinolone vasodilators |
| C01DX Other vasodilators used in cardiac diseases |
| C01E OTHER CARDIAC PREPARATIONS |
| C01EA Prostaglandins |
| C01EB Other cardiac preparations |
| C01EX Other cardiac combination products |
| C02 ANTIHYPERTENSIVES |
| C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING |
| C02AA Rauwolfia alkaloids |
| C02AB Methyldopa |
| C02AC Imidazoline receptor agonists |
| C02B ANTIADRENERGIC AGENTS, GANGLION-BLOCKING |
| C02BA Sulfonium derivatives |
| C02BB Secondary and tertiary amines |
| C02BC Bisquaternary ammonium compounds |
| C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING |
| C02CA Alpha-adrenoreceptor antagonists |
| C02CC Guanidine derivatives |
| C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON |
| C02DA Thiazide derivatives |
| C02DB Hydrazinophthalazine derivatives |
| C02DC Pyrimidine derivatives |
| C02DD Nitroferricyanide derivatives |
| C02DG Guanidine derivatives |
| C02K OTHER ANTIHYPERTENSIVES |
| C02KA Alkaloids, excl. rauwolfia |
| C02KB Tyrosine hydroxylase inhibitors |
| C02KC MAO inhibitors |
| C02KD Serotonin antagonists |
| C02KX Antihypertensive for pulmonary arterial hypertension |
| C02L ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION |
| C02LA Rauwolfia alkaloids and diuretics in combination |
| C02LB Methyldopa and diuretics in combination |
| C02LC Imidazoline receptor agonists in combination with diuretics |
| C02LE Alpha-adrenoreceptor antagonists and diuretics |
| C02LF Guanidine derivatives and diuretics |
| C02LG Hydrazinophthalazine derivatives and diuretics |
| C02LK Alkaloids, excl. rauwolfia, in combination with diuretics |
| C02LL MAO inhibitors and diuretics |
| C02LN Serotonin antagonists and diuretics |
| C02LX Other antihypertensives and diuretics |
| C02N COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02 |
| C03 DIURETICS |
| C03A LOW-CEILING DIURETICS, THIAZIDES |
| C03AA Thiazides, plain |
| C03AB Thiazides and potassium in combination |
| C03AH Thiazides, combinations with psycholeptics and/or analgesics |
| C03AX Thiazides, combinations with other drugs |
| C03B LOW-CEILING DIURETICS, EXCL. THIAZIDES |
| C03BA Sulfonamides, plain |
| C03BB Sulfonamides and potassium in combination |
| C03BC Mercurial diuretics |
| C03BD Xanthine derivatives |
| C03BK Sulfonamides, combinations with other drugs |
| C03BX Other low-ceiling diuretics |
| C03C HIGH-CEILING DIURETICS |
| C03CA Sulfonamides, plain |
| C03CB Sulfonamides and potassium in combination |
| C03CC Aryloxyacetic acid derivatives |
| C03CD Pyrazolone derivatives |
| C03CX Other high-ceiling diuretics |
| C03D POTASSIUM-SPARING AGENTS |
| C03DA Aldosterone antagonists |
| C03DB Other potassium-sparing agents |
| C03E DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION |
| C03EA Low-ceiling diuretics and potassium-sparing agents |
| C03EB High-ceiling diuretics and potassium-sparing agents |
| C03X OTHER DIURETICS |
| C03XA Vasopressin antagonists |
| C04 PERIPHERAL VASODILATORS |
| C04A PERIPHERAL VASODILATORS |
| C04AA 2-amino-1-phenylethanol derivatives |
| C04AB Imidazoline derivatives |
| C04AC Nicotinic acid and derivatives |
| C04AD Purine derivatives |
| C04AE Ergot alkaloids |
| C04AF Enzymes |
| C04AX Other peripheral vasodilators |
| C05 VASOPROTECTIVES |
| C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
| C05AA Corticosteroids |
| C05AB Antibiotics |
| C05AD Local anesthetics |
| C05AE Muscle relaxants |
| C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use |
| C05B ANTIVARICOSE THERAPY |
| C05BA Heparins or heparinoids for topical use |
| C05BB Sclerosing agents for local injection |
| C05BX Other sclerosing agents |
| C05C CAPILLARY STABILIZING AGENTS |
| C05CA Bioflavonoids |
| C05CX Other capillary stabilizing agents |
| C07 BETA BLOCKING AGENTS |
| C07A BETA BLOCKING AGENTS |
| C07AA Beta blocking agents, non-selective |
| C07AB Beta blocking agents, selective |
| C07AG Alpha and beta blocking agents |
| C07B BETA BLOCKING AGENTS AND THIAZIDES |
| C07BA Beta blocking agents, non-selective, and thiazides |
| C07BB Beta blocking agents, selective, and thiazides |
| C07BG Alpha and beta blocking agents and thiazides |
| C07C BETA BLOCKING AGENTS AND OTHER DIURETICS |
| C07CA Beta blocking agents, non-selective, and other diuretics |
| C07CB Beta blocking agents, selective, and other diuretics |
| C07CG Alpha and beta blocking agents and other diuretics |
| C07D BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS |
| C07DA Beta blocking agents, non-selective, thiazides and other diuretics |
| C07DB Beta blocking agents, selective, thiazides and other diuretics |
| C07E BETA BLOCKING AGENTS AND VASODILATORS |
| C07EA Beta blocking agents, non-selective, and vasodilators |
| C07EB Beta blocking agents, selective, and vasodilators |
| C07F BETA BLOCKING AGENTS, OTHER COMBINATIONS |
| C07FB Beta blocking agents and calcium channel blockers |
| C07FX Beta blocking agents, other combinations |
| C08 CALCIUM CHANNEL BLOCKERS |
| C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS |
| C08CA Dihydropyridine derivatives |
| C08CX Other selective calcium channel blockers with mainly vascular effects |
| C08D SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS |
| C08DA Phenylalkylamine derivatives |
| C08DB Benzothiazepine derivatives |
| C08E NON-SELECTIVE CALCIUM CHANNEL BLOCKERS |
| C08EA Phenylalkylamine derivatives |
| C08EX Other non-selective calcium channel blockers |
| C08G CALCIUM CHANNEL BLOCKERS AND DIURETICS |
| C08GA Calcium channel blockers and diuretics |
| C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM |
| C09A ACE INHIBITORS, PLAIN |
| C09AA ACE inhibitors, plain |
| C09B ACE INHIBITORS, COMBINATIONS |
| C09BA ACE inhibitors and diuretics |
| C09BB ACE inhibitors and calcium channel blockers |
| C09BX ACE inhibitors, other combinations |
| C09C ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN |
| C09CA Angiotensin II receptor blockers, plain |
| C09D ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS |
| C09DA Angiotensin II receptor blockers (ARBs) and diuretics |
| C09DB Angiotensin II receptor blockers (ARBs) and calcium channel blockers |
| C09DX Angiotensin II receptor blockers (ARBs), other combinations |
| C09X OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM |
| C09XA Renin-inhibitors |
| C10 LIPID MODIFYING AGENTS |
| C10A LIPID MODIFYING AGENTS, PLAIN |
| C10AA HMG CoA reductase inhibitors |
| C10AB Fibrates |
| C10AC Bile acid sequestrants |
| C10AD Nicotinic acid and derivatives |
| C10AX Other lipid modifying agents |
| C10B LIPID MODIFYING AGENTS, COMBINATIONS |
| C10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents |
| C10BX HMG CoA reductase inhibitors, other combinations |
| DERMATOLOGICALS |
| D01 ANTIFUNGALS FOR DERMATOLOGICAL USE |
| D01A ANTIFUNGALS FOR TOPICAL USE |
| D01AA Antibiotics |
| D01AC Imidazole and triazole derivatives |
| D01AE Other antifungals for topical use |
| D01B ANTIFUNGALS FOR SYSTEMIC USE |
| D01BA Antifungals for systemic use |
| D02 EMOLLIENTS AND PROTECTIVES |
| D02A EMOLLIENTS AND PROTECTIVES |
| D02AA Silicone products |
| D02AB Zinc products |
| D02AC Soft paraffin and fat products |
| D02AD Liquid plasters |
| D02AE Carbamide products |
| D02AF Salicylic acid preparations |
| D02AX Other emollients and protectives |
| D02B PROTECTIVES AGAINST UV-RADIATION |
| D02BA Protectives against UV-radiation for topical use |
| D02BB Protectives against UV-radiation for systemic use |
| D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS |
| D03A CICATRIZANTS |
| D03AA Cod-liver oil ointments |
| D03AX Other cicatrizants |
| D03B ENZYMES |
| D03BA Proteolytic enzymes |
| D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. |
| D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. |
| D04AA Antihistamines for topical use |
| D04AB Anesthetics for topical use |
| D04AX Other antipruritics |
| D05 ANTIPSORIATICS |
| D05A ANTIPSORIATICS FOR TOPICAL USE |
| D05AA Tars |
| D05AC Antracen derivatives |
| D05AD Psoralens for topical use |
| D05AX Other antipsoriatics for topical use |
| D05B ANTIPSORIATICS FOR SYSTEMIC USE |
| D05BA Psoralens for systemic use |
| D05BB Retinoids for treatment of psoriasis |
| D05BX Other antipsoriatics for systemic use |
| D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE |
| D06A ANTIBIOTICS FOR TOPICAL USE |
| D06AA Tetracycline and derivatives |
| D06AX Other antibiotics for topical use |
| D06B CHEMOTHERAPEUTICS FOR TOPICAL USE |
| D06BA Sulfonamides |
| D06BB Antivirals |
| D06BX Other chemotherapeutics |
| D06C ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS |
| D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS |
| D07A CORTICOSTEROIDS, PLAIN |
| D07AA Corticosteroids, weak (group I) |
| D07AB Corticosteroids, moderately potent (group II) |
| D07AC Corticosteroids, potent (group III) |
| D07AD Corticosteroids, very potent (group IV) |
| D07B CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS |
| D07BA Corticosteroids, weak, combinations with antiseptics |
| D07BB Corticosteroids, moderately potent, combinations with antiseptics |
| D07BC Corticosteroids, potent, combinations with antiseptics |
| D07BD Corticosteroids, very potent, combinations with antiseptics |
| D07C CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS |
| D07CA Corticosteroids, weak, combinations with antibiotics |
| D07CB Corticosteroids, moderately potent, combinations with antibiotics |
| D07CC Corticosteroids, potent, combinations with antibiotics |
| D07CD Corticosteroids, very potent, combinations with antibiotics |
| D07X CORTICOSTEROIDS, OTHER COMBINATIONS |
| D07XA Corticosteroids, weak, other combinations |
| D07XB Corticosteroids, moderately potent, other combinations |
| D07XC Corticosteroids, potent, other combinations |
| D07XD Corticosteroids, very potent, other combinations |
| D08 ANTISEPTICS AND DISINFECTANTS |
| D08A ANTISEPTICS AND DISINFECTANTS |
| D08AA Acridine derivatives |
| D08AB Aluminium agents |
| D08AC Biguanides and amidines |
| D08AD Boric acid products |
| D08AE Phenol and derivatives |
| D08AF Nitrofuran derivatives |
| D08AG Iodine products |
| D08AH Quinoline derivatives |
| D08AJ Quaternary ammonium compounds |
| D08AK Mercurial products |
| D08AL Silver compounds |
| D08AX Other antiseptics and disinfectants |
| D09 MEDICATED DRESSINGS |
| D09A MEDICATED DRESSINGS |
| D09AA Medicated dressings with antiinfectives |
| D09AB Zinc bandages |
| D09AX Soft paraffin dressings |
| D10 ANTI-ACNE PREPARATIONS |
| D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE |
| D10AA Corticosteroids, combinations for treatment of acne |
| D10AB Preparations containing sulfur |
| D10AD Retinoids for topical use in acne |
| D10AE Peroxides |
| D10AF Antiinfectives for treatment of acne |
| D10AX Other anti-acne preparations for topical use |
| D10B ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE |
| D10BA Retinoids for treatment of acne |
| D10BX Other anti-acne preparations for systemic use |
| D11 OTHER DERMATOLOGICAL PREPARATIONS |
| D11A OTHER DERMATOLOGICAL PREPARATIONS |
| D11AA Antihidrotics |
| D11AC Medicated shampoos |
| D11AE Androgens for topical use |
| D11AF Wart and anti-corn preparations |
| D11AH Agents for dermatitis, excluding corticosteroids |
| D11AX Other dermatologicals |
| GENITO URINARY SYSTEM AND SEX HORMONES |
| G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS |
| G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS |
| G01AA Antibiotics |
| G01AB Arsenic compounds |
| G01AC Quinoline derivatives |
| G01AD Organic acids |
| G01AE Sulfonamides |
| G01AF Imidazole derivatives |
| G01AG Triazole derivatives |
| G01AX Other antiinfectives and antiseptics |
| G01B ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS |
| G01BA Antibiotics and corticosteroids |
| G01BC Quinoline derivatives and corticosteroids |
| G01BD Antiseptics and corticosteroids |
| G01BE Sulfonamides and corticosteroids |
| G01BF Imidazole derivatives and corticosteroids |
| G02 OTHER GYNECOLOGICALS |
| G02A UTEROTONICS |
| G02AB Ergot alkaloids |
| G02AC Ergot alkaloids and oxytocin incl. analogues, in combination |
| G02AD Prostaglandins |
| G02AX Other uterotonics |
| G02B CONTRACEPTIVES FOR TOPICAL USE |
| G02BA Intrauterine contraceptives |
| G02BB Intravaginal contraceptives |
| G02C OTHER GYNECOLOGICALS |
| G02CA Sympathomimetics, labour repressants |
| G02CB Prolactine inhibitors |
| G02CC Antiinflammatory products for vaginal administration |
| G02CX Other gynecologicals |
| G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM |
| G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| G03AA Progestogens and estrogens, fixed combinations |
| G03AB Progestogens and estrogens, sequential preparations |
| G03AC Progestogens |
| G03AD Emergency contraceptives |
| G03B ANDROGENS |
| G03BA 3-oxoandrosten (4) derivatives |
| G03BB 5-androstanon (3) derivatives |
| G03C ESTROGENS |
| G03CA Natural and semisynthetic estrogens, plain |
| G03CB Synthetic estrogens, plain |
| G03CC Estrogens, combinations with other drugs |
| G03CX Other estrogens |
| G03D PROGESTOGENS |
| G03DA Pregnen (4) derivatives |
| G03DB Pregnadien derivatives |
| G03DC Estren derivatives |
| G03E ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION |
| G03EA Androgens and estrogens |
| G03EB Androgen, progestogen and estrogen in combination |
| G03EK Androgens and female sex hormones in combination with other drugs |
| G03F PROGESTOGENS AND ESTROGENS IN COMBINATION |
| G03FA Progestogens and estrogens, fixed combinations |
| G03FB Progestogens and estrogens, sequential preparations |
| G03G GONADOTROPINS AND OTHER OVULATION STIMULANTS |
| G03GA Gonadotropins |
| G03GB Ovulation stimulants, synthetic |
| G03H ANTIANDROGENS |
| G03HA Antiandrogens, plain |
| G03HB Antiandrogens and estrogens |
| G03X OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM |
| G03XA Antigonadotropins and similar agents |
| G03XB Progesterone receptor modulators |
| G03XC Selective estrogen receptor modulators |
| G03XX Other sex hormones and modulators of the genital system |
| G04 UROLOGICALS |
| G04B UROLOGICALS |
| G04BA Acidifiers |
| G04BC Urinary concrement solvents |
| G04BD Urinary antispasmodics |
| G04BE Drugs used in erectile dysfunction |
| G04BX Other urologicals |
| G04C DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| G04CA Alpha-adrenoreceptor antagonists |
| G04CB Testosterone-5-alpha reductase inhibitors |
| G04CX Other drugs used in benign prostatic hypertrophy |
| SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS |
| H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES |
| H01A ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES |
| H01AA ACTH |
| H01AB Thyrotropin |
| H01AC Somatropin and somatropin agonists |
| H01AX Other anterior pituitary lobe hormones and analogues |
| H01B POSTERIOR PITUITARY LOBE HORMONES |
| H01BA Vasopressin and analogues |
| H01BB Oxytocin and analogues |
| H01C HYPOTHALAMIC HORMONES |
| H01CA Gonadotropin-releasing hormones |
| H01CB Somatostatin and analogues |
| H01CC Anti-gonadotropin-releasing hormones |
| H02 CORTICOSTEROIDS FOR SYSTEMIC USE |
| H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
| H02AA Mineralocorticoids |
| H02AB Glucocorticoids |
| H02B CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS |
| H02BX Corticosteroids for systemic use, combinations |
| H02C ANTIADRENAL PREPARATIONS |
| H02CA Anticorticosteroids |
| H03 THYROID THERAPY |
| H03A THYROID PREPARATIONS |
| H03AA Thyroid hormones |
| H03B ANTITHYROID PREPARATIONS |
| H03BA Thiouracils |
| H03BB Sulfur-containing imidazole derivatives |
| H03BC Perchlorates |
| H03BX Other antithyroid preparations |
| H03C IODINE THERAPY |
| H03CA Iodine therapy |
| H04 PANCREATIC HORMONES |
| H04A GLYCOGENOLYTIC HORMONES |
| H04AA Glycogenolytic hormones |
| H05 CALCIUM HOMEOSTASIS |
| H05A PARATHYROID HORMONES AND ANALOGUES |
| H05AA Parathyroid hormones and analogues |
| H05B ANTI-PARATHYROID AGENTS |
| H05BA Calcitonin preparations |
| H05BX Other anti-parathyroid agents |
| ANTIINFECTIVES FOR SYSTEMIC USE |
| J01 ANTIBACTERIALS FOR SYSTEMIC USE |
| J01A TETRACYCLINES |
| J01AA Tetracyclines |
| J01B AMPHENICOLS |
| J01BA Amphenicols |
| J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| J01CA Penicillins with extended spectrum |
| J01CE Beta-lactamase sensitive penicillins |
| J01CF Beta-lactamase resistant penicillins |
| J01CG Beta-lactamase inhibitors |
| J01CR Combinations of penicillins, incl. beta-lactamase inhibitors |
| J01D OTHER BETA-LACTAM ANTIBACTERIALS |
| J01DB First-generation cephalosporins |
| J01DC Second-generation cephalosporins |
| J01DD Third-generation cephalosporins |
| J01DE Fourth-generation cephalosporins |
| J01DF Monobactams |
| J01DH Carbapenems |
| J01DI Other cephalosporins and penems |
| J01E SULFONAMIDES AND TRIMETHOPRIM |
| J01EA Trimethoprim and derivatives |
| J01EB Short-acting sulfonamides |
| J01EC Intermediate-acting sulfonamides |
| J01ED Long-acting sulfonamides |
| J01EE Combinations of sulfonamides and trimethoprim, incl. derivatives |
| J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
| J01FA Macrolides |
| J01FF Lincosamides |
| J01FG Streptogramins |
| J01G AMINOGLYCOSIDE ANTIBACTERIALS |
| J01GA Streptomycins |
| J01GB Other aminoglycosides |
| J01M QUINOLONE ANTIBACTERIALS |
| J01MA Fluoroquinolones |
| J01MB Other quinolones |
| J01R COMBINATIONS OF ANTIBACTERIALS |
| J01RA Combinations of antibacterials |
| J01X OTHER ANTIBACTERIALS |
| J01XA Glycopeptide antibacterials |
| J01XB Polymyxins |
| J01XC Steroid antibacterials |
| J01XD Imidazole derivatives |
| J01XE Nitrofuran derivatives |
| J01XX Other antibacterials |
| J02 ANTIMYCOTICS FOR SYSTEMIC USE |
| J02A ANTIMYCOTICS FOR SYSTEMIC USE |
| J02AA Antibiotics |
| J02AB Imidazole derivatives |
| J02AC Triazole derivatives |
| J02AX Other antimycotics for systemic use |
| J04 ANTIMYCOBACTERIALS |
| J04A DRUGS FOR TREATMENT OF TUBERCULOSIS |
| J04AA Aminosalicylic acid and derivatives |
| J04AB Antibiotics |
| J04AC Hydrazides |
| J04AD Thiocarbamide derivatives |
| J04AK Other drugs for treatment of tuberculosis |
| J04AM Combinations of drugs for treatment of tuberculosis |
| J04B DRUGS FOR TREATMENT OF LEPRA |
| J04BA Drugs for treatment of lepra |
| J05 ANTIVIRALS FOR SYSTEMIC USE |
| J05A DIRECT ACTING ANTIVIRALS |
| J05AA Thiosemicarbazones |
| J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors |
| J05AC Cyclic amines |
| J05AD Phosphonic acid derivatives |
| J05AE Protease inhibitors |
| J05AF Nucleoside and nucleotide reverse transcriptase inhibitors |
| J05AG Non-nucleoside reverse transcriptase inhibitor |
| J05AH Neuraminidase inhibitors |
| J05AP Antivirals for treatment of HCV infections |
| J05AR Antivirals for treatment of HIV infections, combinations |
| J05AX Other antivirals |
| J06 IMMUNE SERA AND IMMUNOGLOBULINS |
| J06A IMMUNE SERA |
| J06AA Immune sera |
| J06B IMMUNOGLOBULINS |
| J06BA Immunoglobulins, normal human |
| J06BB Specific immunoglobulins |
| J06BC Other immunoglobulins |
| J07 VACCINES |
| J07A BACTERIAL VACCINES |
| J07AC Anthrax vaccines |
| J07AD Brucellosis vaccines |
| J07AE Cholera vaccines |
| J07AF Diphtheria vaccines |
| J07AG Hemophilus influenzae B vaccines |
| J07AH Meningococcal vaccines |
| J07AJ Pertussis vaccines |
| J07AK Plague vaccines |
| J07AL Pneumococcal vaccines |
| J07AM Tetanus vaccines |
| J07AN Tuberculosis vaccines |
| J07AP Typhoid vaccines |
| J07AR Typhus (exanthematicus) vaccines |
| J07AX Other bacterial vaccines |
| J07B VIRAL VACCINES |
| J07BA Encephalitis vaccines |
| J07BB Influenza vaccines |
| J07BC Hepatitis vaccines |
| J07BD Measles vaccines |
| J07BE Mumps vaccines |
| J07BF Poliomyelitis vaccines |
| J07BG Rabies vaccines |
| J07BH Rota virus diarrhea vaccines |
| J07BJ Rubella vaccines |
| J07BK Varicella zoster vaccines |
| J07BL Yellow fever vaccines |
| J07BM Papillomavirus vaccines |
| J07BX Other viral vaccines |
| J07C BACTERIAL AND VIRAL VACCINES, COMBINED |
| J07CA Bacterial and viral vaccines, combined |
| J07X OTHER VACCINES |
| ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
| L01 ANTINEOPLASTIC AGENTS |
| L01A ALKYLATING AGENTS |
| L01AA Nitrogen mustard analogues |
| L01AB Alkyl sulfonates |
| L01AC Ethylene imines |
| L01AD Nitrosoureas |
| L01AG Epoxides |
| L01AX Other alkylating agents |
| L01B ANTIMETABOLITES |
| L01BA Folic acid analogues |
| L01BB Purine analogues |
| L01BC Pyrimidine analogues |
| L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| L01CA Vinca alkaloids and analogues |
| L01CB Podophyllotoxin derivatives |
| L01CC Colchicine derivatives |
| L01CD Taxanes |
| L01CX Other plant alkaloids and natural products |
| L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
| L01DA Actinomycines |
| L01DB Anthracyclines and related substances |
| L01DC Other cytotoxic antibiotics |
| L01X OTHER ANTINEOPLASTIC AGENTS |
| L01XA Platinum compounds |
| L01XB Methylhydrazines |
| L01XC Monoclonal antibodies |
| L01XD Sensitizers used in photodynamic/radiation therapy |
| L01XE Protein kinase inhibitors |
| L01XX Other antineoplastic agents |
| L01XY Combinations of antineoplastic agents |
| L02 ENDOCRINE THERAPY |
| L02A HORMONES AND RELATED AGENTS |
| L02AA Estrogens |
| L02AB Progestogens |
| L02AE Gonadotropin releasing hormone analogues |
| L02AX Other hormones |
| L02B HORMONE ANTAGONISTS AND RELATED AGENTS |
| L02BA Anti-estrogens |
| L02BB Anti-androgens |
| L02BG Aromatase inhibitors |
| L02BX Other hormone antagonists and related agents |
| L03 IMMUNOSTIMULANTS |
| L03A IMMUNOSTIMULANTS |
| L03AA Colony stimulating factors |
| L03AB Interferons |
| L03AC Interleukins |
| L03AX Other immunostimulants |
| L04 IMMUNOSUPPRESSANTS |
| L04A IMMUNOSUPPRESSANTS |
| L04AA Selective immunosuppressants |
| L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors |
| L04AC Interleukin inhibitors |
| L04AD Calcineurin inhibitors |
| L04AX Other immunosuppressants |
| MUSCULO-SKELETAL SYSTEM |
| M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS |
| M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS |
| M01AA Butylpyrazolidines |
| M01AB Acetic acid derivatives and related substances |
| M01AC Oxicams |
| M01AE Propionic acid derivatives |
| M01AG Fenamates |
| M01AH Coxibs |
| M01AX Other antiinflammatory and antirheumatic agents, non-steroids |
| M01B ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION |
| M01BA Antiinflammatory/antirheumatic agents in combination with corticosteroids |
| M01BX Other antiinflammatory/antirheumatic agents in combination with other drugs |
| M01C SPECIFIC ANTIRHEUMATIC AGENTS |
| M01CA Quinolines |
| M01CB Gold preparations |
| M01CC Penicillamine and similar agents |
| M01CX Other specific antirheumatic agents |
| M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN |
| M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN |
| M02AA Antiinflammatory preparations, non-steroids for topical use |
| M02AB Capsaicin and similar agents |
| M02AC Preparations with salicylic acid derivatives |
| M02AX Other topical products for joint and muscular pain |
| M03 MUSCLE RELAXANTS |
| M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS |
| M03AA Curare alkaloids |
| M03AB Choline derivatives |
| M03AC Other quaternary ammonium compounds |
| M03AX Other muscle relaxants, peripherally acting agents |
| M03B MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS |
| M03BA Carbamic acid esters |
| M03BB Oxazol, thiazine, and triazine derivatives |
| M03BC Ethers, chemically close to antihistamines |
| M03BX Other centrally acting agents |
| M03C MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS |
| M03CA Dantrolene and derivatives |
| M04 ANTIGOUT PREPARATIONS |
| M04A ANTIGOUT PREPARATIONS |
| M04AA Preparations inhibiting uric acid production |
| M04AB Preparations increasing uric acid excretion |
| M04AC Preparations with no effect on uric acid metabolism |
| M04AX Other antigout preparations |
| M05 DRUGS FOR TREATMENT OF BONE DISEASES |
| M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| M05BA Bisphosphonates |
| M05BB Bisphosphonates, combinations |
| M05BC Bone morphogenetic proteins |
| M05BX Other drugs affecting bone structure and mineralization |
| M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM |
| M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM |
| M09AA Quinine and derivatives |
| M09AB Enzymes |
| M09AX Other drugs for disorders of the musculo-skeletal system |
| NERVOUS SYSTEM |
| N01 ANESTHETICS |
| N01A ANESTHETICS, GENERAL |
| N01AA Ethers |
| N01AB Halogenated hydrocarbons |
| N01AF Barbiturates, plain |
| N01AG Barbiturates in combination with other drugs |
| N01AH Opioid anesthetics |
| N01AX Other general anesthetics |
| N01B ANESTHETICS, LOCAL |
| N01BA Esters of aminobenzoic acid |
| N01BB Amides |
| N01BC Esters of benzoic acid |
| N01BX Other local anesthetics |
| N02 ANALGESICS |
| N02A OPIOIDS |
| N02AA Natural opium alkaloids |
| N02AB Phenylpiperidine derivatives |
| N02AC Diphenylpropylamine derivatives |
| N02AD Benzomorphan derivatives |
| N02AE Oripavine derivatives |
| N02AF Morphinan derivatives |
| N02AG Opioids in combination with antispasmodics |
| N02AJ Opioids in combination with non-opioid analgesics |
| N02AX Other opioids |
| N02B OTHER ANALGESICS AND ANTIPYRETICS |
| N02BA Salicylic acid and derivatives |
| N02BB Pyrazolones |
| N02BE Anilides |
| N02BG Other analgesics and antipyretics |
| N02C ANTIMIGRAINE PREPARATIONS |
| N02CA Ergot alkaloids |
| N02CB Corticosteroid derivatives |
| N02CC Selective serotonin (5HT1) agonists |
| N02CD Calcitonin gene-related peptide (CGRP) antagonists |
| N02CX Other antimigraine preparations |
| N03 ANTIEPILEPTICS |
| N03A ANTIEPILEPTICS |
| N03AA Barbiturates and derivatives |
| N03AB Hydantoin derivatives |
| N03AC Oxazolidine derivatives |
| N03AD Succinimide derivatives |
| N03AE Benzodiazepine derivatives |
| N03AF Carboxamide derivatives |
| N03AG Fatty acid derivatives |
| N03AX Other antiepileptics |
| N04 ANTI-PARKINSON DRUGS |
| N04A ANTICHOLINERGIC AGENTS |
| N04AA Tertiary amines |
| N04AB Ethers chemically close to antihistamines |
| N04AC Ethers of tropine or tropine derivatives |
| N04B DOPAMINERGIC AGENTS |
| N04BA Dopa and dopa derivatives |
| N04BB Adamantane derivatives |
| N04BC Dopamine agonists |
| N04BD Monoamine oxidase B inhibitors |
| N04BX Other dopaminergic agents |
| N05 PSYCHOLEPTICS |
| N05A ANTIPSYCHOTICS |
| N05AA Phenothiazines with aliphatic side-chain |
| N05AB Phenothiazines with piperazine structure |
| N05AC Phenothiazines with piperidine structure |
| N05AD Butyrophenone derivatives |
| N05AE Indole derivatives |
| N05AF Thioxanthene derivatives |
| N05AG Diphenylbutylpiperidine derivatives |
| N05AH Diazepines, oxazepines and thiazepines |
| N05AL Benzamides |
| N05AN Lithium |
| N05AX Other antipsychotics |
| N05B ANXIOLYTICS |
| N05BA Benzodiazepine derivatives |
| N05BB Diphenylmethane derivatives |
| N05BC Carbamates |
| N05BD Dibenzo-bicyclo-octadiene derivatives |
| N05BE Azaspirodecanedione derivatives |
| N05BX Other anxiolytics |
| N05C HYPNOTICS AND SEDATIVES |
| N05CA Barbiturates, plain |
| N05CB Barbiturates, combinations |
| N05CC Aldehydes and derivatives |
| N05CD Benzodiazepine derivatives |
| N05CE Piperidinedione derivatives |
| N05CF Benzodiazepine related drugs |
| N05CH Melatonin receptor agonists |
| N05CM Other hypnotics and sedatives |
| N05CX Hypnotics and sedatives in combination, excl. barbiturates |
| N06 PSYCHOANALEPTICS |
| N06A ANTIDEPRESSANTS |
| N06AA Non-selective monoamine reuptake inhibitors |
| N06AB Selective serotonin reuptake inhibitors |
| N06AF Monoamine oxidase inhibitors, non-selective |
| N06AG Monoamine oxidase A inhibitors |
| N06AX Other antidepressants |
| N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS |
| N06BA Centrally acting sympathomimetics |
| N06BC Xanthine derivatives |
| N06BX Other psychostimulants and nootropics |
| N06C PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION |
| N06CA Antidepressants in combination with psycholeptics |
| N06CB Psychostimulants in combination with psycholeptics |
| N06D ANTI-DEMENTIA DRUGS |
| N06DA Anticholinesterases |
| N06DX Other anti-dementia drugs |
| N07 OTHER NERVOUS SYSTEM DRUGS |
| N07A PARASYMPATHOMIMETICS |
| N07AA Anticholinesterases |
| N07AB Choline esters |
| N07AX Other parasympathomimetics |
| N07B DRUGS USED IN ADDICTIVE DISORDERS |
| N07BA Drugs used in nicotine dependence |
| N07BB Drugs used in alcohol dependence |
| N07BC Drugs used in opioid dependence |
| N07C ANTIVERTIGO PREPARATIONS |
| N07CA Antivertigo preparations |
| N07X OTHER NERVOUS SYSTEM DRUGS |
| N07XA Gangliosides and ganglioside derivatives |
| N07XX Other nervous system drugs |
| ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS |
| P01 ANTIPROTOZOALS |
| P01A AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES |
| P01AA Hydroxyquinoline derivatives |
| P01AB Nitroimidazole derivatives |
| P01AC Dichloroacetamide derivatives |
| P01AR Arsenic compounds |
| P01AX Other agents against amoebiasis and other protozoal diseases |
| P01B ANTIMALARIALS |
| P01BA Aminoquinolines |
| P01BB Biguanides |
| P01BC Methanolquinolines |
| P01BD Diaminopyrimidines |
| P01BE Artemisinin and derivatives, plain |
| P01BF Artemisinin and derivatives, combinations |
| P01BX Other antimalarials |
| P01C AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS |
| P01CA Nitroimidazole derivatives |
| P01CB Antimony compounds |
| P01CC Nitrofuran derivatives |
| P01CD Arsenic compounds |
| P01CX Other agents against leishmaniasis and trypanosomiasis |
| P02 ANTHELMINTICS |
| P02B ANTITREMATODALS |
| P02BA Quinoline derivatives and related substances |
| P02BB Organophosphorous compounds |
| P02BX Other antitrematodal agents |
| P02C ANTINEMATODAL AGENTS |
| P02CA Benzimidazole derivatives |
| P02CB Piperazine and derivatives |
| P02CC Tetrahydropyrimidine derivatives |
| P02CE Imidazothiazole derivatives |
| P02CF Avermectines |
| P02CX Other antinematodals |
| P02D ANTICESTODALS |
| P02DA Salicylic acid derivatives |
| P02DX Other anticestodals |
| P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS |
| P03A ECTOPARASITICIDES, INCL. SCABICIDES |
| P03AA Sulfur containing products |
| P03AB Chlorine containing products |
| P03AC Pyrethrines, incl. synthetic compounds |
| P03AX Other ectoparasiticides, incl. scabicides |
| P03B INSECTICIDES AND REPELLENTS |
| P03BA Pyrethrines |
| P03BX Other insecticides and repellents |
| RESPIRATORY SYSTEM |
| R01 NASAL PREPARATIONS |
| R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE |
| R01AA Sympathomimetics, plain |
| R01AB Sympathomimetics, combinations excl. corticosteroids |
| R01AC Antiallergic agents, excl. corticosteroids |
| R01AD Corticosteroids |
| R01AX Other nasal preparations |
| R01B NASAL DECONGESTANTS FOR SYSTEMIC USE |
| R01BA Sympathomimetics |
| R02 THROAT PREPARATIONS |
| R02A THROAT PREPARATIONS |
| R02AA Antiseptics |
| R02AB Antibiotics |
| R02AD Anesthetics, local |
| R02AX Other throat preparetions |
| R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| R03A ADRENERGICS, INHALANTS |
| R03AA Alpha- and beta-adrenoreceptor agonists |
| R03AB Non-selective beta-adrenoreceptor agonists |
| R03AC Selective beta-2-adrenoreceptor agonists |
| R03AH Combinations of adrenergics |
| R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics |
| R03AL Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids |
| R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| R03BA Glucocorticoids |
| R03BB Anticholinergics |
| R03BC Antiallergic agents, excl. corticosteroids |
| R03BX Other drugs for obstructive airway diseases, inhalants |
| R03C ADRENERGICS FOR SYSTEMIC USE |
| R03CA Alpha- and beta-adrenoreceptor agonists |
| R03CB Non-selective beta-adrenoreceptor agonists |
| R03CC Selective beta-2-adrenoreceptor agonists |
| R03CK Adrenergics and other drugs for obstructive airway diseases |
| R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| R03DA Xanthines |
| R03DB Xanthines and adrenergics |
| R03DC Leukotriene receptor antagonists |
| R03DX Other systemic drugs for obstructive airway diseases |
| R05 COUGH AND COLD PREPARATIONS |
| R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS |
| R05CA Expectorants |
| R05CB Mucolytics |
| R05D COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS |
| R05DA Opium alkaloids and derivatives |
| R05DB Other cough suppressants |
| R05F COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS |
| R05FA Opium derivatives and expectorants |
| R05FB Other cough suppressants and expectorants |
| R05X OTHER COLD PREPARATIONS |
| R06 ANTIHISTAMINES FOR SYSTEMIC USE |
| R06A ANTIHISTAMINES FOR SYSTEMIC USE |
| R06AA Aminoalkyl ethers |
| R06AB Substituted alkylamines |
| R06AC Substituted ethylene diamines |
| R06AD Phenothiazine derivatives |
| R06AE Piperazine derivatives |
| R06AK Combinations of antihistamines |
| R06AX Other antihistamines for systemic use |
| R07 OTHER RESPIRATORY SYSTEM PRODUCTS |
| R07A OTHER RESPIRATORY SYSTEM PRODUCTS |
| R07AA Lung surfactants |
| R07AB Respiratory stimulants |
| R07AX Other respiratory system products |
| SENSORY ORGANS |
| S01 OPHTHALMOLOGICALS |
| S01A ANTIINFECTIVES |
| S01AA Antibiotics |
| S01AB Sulfonamides |
| S01AD Antivirals |
| S01AE Fluoroquinolones |
| S01AX Other antiinfectives |
| S01B ANTIINFLAMMATORY AGENTS |
| S01BA Corticosteroids, plain |
| S01BB Corticosteroids and mydriatics in combination |
| S01BC Antiinflammatory agents, non-steroids |
| S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION |
| S01CA Corticosteroids and antiinfectives in combination |
| S01CB Corticosteroids/antiinfectives/mydriatics in combination |
| S01CC Antiinflammatory agents, non-steroids and antiinfectives in combination |
| S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| S01EA Sympathomimetics in glaucoma therapy |
| S01EB Parasympathomimetics |
| S01EC Carbonic anhydrase inhibitors |
| S01ED Beta blocking agents |
| S01EE Prostaglandin analogues |
| S01EX Other antiglaucoma preparations |
| S01F MYDRIATICS AND CYCLOPLEGICS |
| S01FA Anticholinergics |
| S01FB Sympathomimetics excl. antiglaucoma preparations |
| S01G DECONGESTANTS AND ANTIALLERGICS |
| S01GA Sympathomimetics used as decongestants |
| S01GX Other antiallergics |
| S01H LOCAL ANESTHETICS |
| S01HA Local anesthetics |
| S01J DIAGNOSTIC AGENTS |
| S01JA Colouring agents |
| S01JX Other ophthalmological diagnostic agents |
| S01K SURGICAL AIDS |
| S01KA Viscoelastic substances |
| S01KX Other surgical aids |
| S01L OCULAR VASCULAR DISORDER AGENTS |
| S01LA Antineovascularisation agents |
| S01X OTHER OPHTHALMOLOGICALS |
| S01XA Other ophthalmologicals |
| S02 OTOLOGICALS |
| S02A ANTIINFECTIVES |
| S02AA Antiinfectives |
| S02B CORTICOSTEROIDS |
| S02BA Corticosteroids |
| S02C CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION |
| S02CA Corticosteroids and antiinfectives in combination |
| S02D OTHER OTOLOGICALS |
| S02DA Analgesics and anesthetics |
| S02DC Indifferent preparations |
| S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS |
| S03A ANTIINFECTIVES |
| S03AA Antiinfectives |
| S03B CORTICOSTEROIDS |
| S03BA Corticosteroids |
| S03C CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION |
| S03CA Corticosteroids and antiinfectives in combination |
| S03D OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS |
| VARIOUS |
| V01 ALLERGENS |
| V01A ALLERGENS |
| V01AA Allergen extracts |
| V03 ALL OTHER THERAPEUTIC PRODUCTS |
| V03A ALL OTHER THERAPEUTIC PRODUCTS |
| V03AB Antidotes |
| V03AC Iron chelating agents |
| V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia |
| V03AF Detoxifying agents for antineoplastic treatment |
| V03AG Drugs for treatment of hypercalcemia |
| V03AH Drugs for treatment of hypoglycemia |
| V03AK Tissue adhesives |
| V03AM Drugs for embolisation |
| V03AN Medical gases |
| V03AX Other therapeutic products |
| V03AZ Nerve depressants |
| V04 DIAGNOSTIC AGENTS |
| V04B URINE TESTS |
| V04C OTHER DIAGNOSTIC AGENTS |
| V04CA Tests for diabetes |
| V04CB Tests for fat absorption |
| V04CC Tests for bile duct patency |
| V04CD Tests for pituitary function |
| V04CE Tests for liver functional capacity |
| V04CF Tuberculosis diagnostics |
| V04CG Tests for gastric secretion |
| V04CH Tests for renal function |
| V04CJ Tests for thyreoidea function |
| V04CK Tests for pancreatic function |
| V04CL Tests for allergic diseases |
| V04CM Tests for fertility disturbances |
| V04CX Other diagnostic agents |
| V06 GENERAL NUTRIENTS |
| V06A DIET FORMULATIONS FOR TREATMENT OF OBESITY |
| V06AA Low-energy diets |
| V06B PROTEIN SUPPLEMENTS |
| V06C INFANT FORMULAS |
| V06CA Nutrients without phenylalanine |
| V06D OTHER NUTRIENTS |
| V06DA Carbohydrates/proteins/minerals/vitamins, combinations |
| V06DB Fat/carbohydrates/proteins/minerals/vitamins, combinations |
| V06DC Carbohydrates |
| V06DD Amino acids, incl. combinations with polypeptides |
| V06DE Amino acids/carbohydrates/minerals/vitamins, combinations |
| V06DF Milk substitutes |
| V06DX Other combinations of nutrients |
| V07 ALL OTHER NON-THERAPEUTIC PRODUCTS |
| V07A ALL OTHER NON-THERAPEUTIC PRODUCTS |
| V07AA Plasters |
| V07AB Solvents and diluting agents, incl. irrigating solutions |
| V07AC Blood transfusion, auxiliary products |
| V07AD Blood tests, auxiliary products |
| V07AN Incontinence equipment |
| V07AR Sensitivity tests, discs and tablets |
| V07AS Stomi equipment |
| V07AT Cosmetics |
| V07AV Technical disinfectants |
| V07AX Washing agents etc. |
| V07AY Other non-therapeutic auxiliary products |
| V07AZ Chemicals and reagents for analysis |
| V08 CONTRAST MEDIA |
| V08A X-RAY CONTRAST MEDIA, IODINATED |
| V08AA Watersoluble, nephrotropic, high osmolar X-ray contrast media |
| V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media |
| V08AC Watersoluble, hepatotropic X-ray contrast media |
| V08AD Non-watersoluble X-ray contrast media |
| V08B X-RAY CONTRAST MEDIA, NON-IODINATED |
| V08BA Barium sulfate containing X-ray contrast media |
| V08C MAGNETIC RESONANCE IMAGING CONTRAST MEDIA |
| V08CA Paramagnetic contrast media |
| V08CB Superparamagnetic contrast media |
| V08CX Other magnetic resonance imaging contrast media |
| V08D ULTRASOUND CONTRAST MEDIA |
| V08DA Ultrasound contrast media |
| V09 DIAGNOSTIC RADIOPHARMACEUTICALS |
| V09A CENTRAL NERVOUS SYSTEM |
| V09AA Technetium (99mTc) compounds |
| V09AB Iodine (123I) compounds |
| V09AX Other central nervous system diagnostic radiopharmaceuticals |
| V09B SKELETON |
| V09BA Technetium (99mTc) compounds |
| V09C RENAL SYSTEM |
| V09CA Technetium (99mTc) compounds |
| V09CX Other renal system diagnostic radiopharmaceuticals |
| V09D HEPATIC AND RETICULO ENDOTHELIAL SYSTEM |
| V09DA Technetium (99mTc) compounds |
| V09DB Technetium (99mTc), particles and colloids |
| V09DX Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals |
| V09E RESPIRATORY SYSTEM |
| V09EA Technetium (99mTc), inhalants |
| V09EB Technetium (99mTc), particles for injection |
| V09EX Other respiratory system diagnostic radiopharmaceuticals |
| V09F THYROID |
| V09FX Various thyroid diagnostic radiopharmaceuticals |
| V09G CARDIOVASCULAR SYSTEM |
| V09GA Technetium (99mTc) compounds |
| V09GB Iodine (125I) compounds |
| V09GX Other cardiovascular system diagnostic radiopharmaceuticals |
| V09H INFLAMMATION AND INFECTION DETECTION |
| V09HA Technetium (99mTc) compounds |
| V09HB Indium (111In) compounds |
| V09HX Other diagnostic radiopharmaceuticals for inflammation and infection detection |
| V09I TUMOUR DETECTION |
| V09IA Technetium (99mTc) compounds |
| V09IB Indium (111In) compounds |
| V09IX Other diagnostic radiopharmaceuticals for tumour detection |
| V09X OTHER DIAGNOSTIC RADIOPHARMACEUTICALS |
| V09XA Iodine (131I) compounds |
| V09XX Various diagnostic radiopharmaceuticals |
| V10 THERAPEUTIC RADIOPHARMACEUTICALS |
| V10A ANTIINFLAMMATORY AGENTS |
| V10AA Yttrium (90Y) compounds |
| V10AX Other antiinflammatory therapeutic radiopharmaceuticals |
| V10B PAIN PALLIATION (BONE SEEKING AGENTS) |
| V10BX Various pain palliation radiopharmaceuticals |
| V10X OTHER THERAPEUTIC RADIOPHARMACEUTICALS |
| V10XA Iodine (131I) compounds |
| V10XX Various therapeutic radiopharmaceuticals |